03
Aug
2023
14:00
BST
09:00
EDT
Webinar
Late Cardiac Events After Allogeneic Stem Cell Transplant: Incidence, Risk Factors, and Impact on Overall Survival
-
Views:
2502
-
Likes:
11
Overview
In this month's Journal Club, Dr Stefanie Mundnich (Red Salud Vitacura Santiago, CL), Dr Jose Alvarez-Cardona (New York University School of Medicine, US), Prof Dan Lenihan (Saint Francis Healthcare System, US) and Prof Joe Carver (University of Pennsylvania, US) discuss the article “Late Cardiac Events After Allogeneic Stem Cell Transplant: Incidence, Risk Factors, and Impact on Overall Survival”.
The article explores the incidence, risk factors and overall impact of late cardiac events on survival in patients who have undergone allogeneic stem cell transplant (alloSCT). AlloSCT is a treatment option for various haematological malignancies and other disorders. While significant advancements have been made in the field, the long-term effects on cardiovascular health remain a concern.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS are collectively improving the overall outcomes including survival and quality of life. IC-OS aim to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
Support Statement
This is an independent activity run by the International Cardio-Oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. The IC-OS has been provided support to deliver this webinar series by AstraZeneca, BMS/Pfizer Alliance, Eli Lilly and Roche through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
Faculty:
Stefanie Mundnich
Jose Alvarez-Cardona
Dan Lenihan
Joe Carver
This broadcast is supported by
Faculty Biographies
Stefanie Mundnich
Dr Stefanie Mundnich is a Cardiologist at Red Salud Vitacura Santiago, Vitacura, CL.
She obtained her medical degree at Pontifical Catholic University of Chile, specialised in Internal Medicine and Cardiology at the University of Chile, and completed her training with a Master in Cardio-Oncology.
During the last six years, she developed her experience in the field of Cardio-Oncology, both as Coordinator of the Cardio-Oncology programme at RedSalud Cancer Institute and Founder of Fundación Cardio-Onco, in Santiago de Chile.
Dr Mundnich is a board certified Cardio-Oncologist by the International Society of Cardio-Oncology (ICOS), member of the International Society of Cardio-Oncology (ICOS), the Ibero-Latin American Cardio-Oncology Group (ILACO) and the Cardio-Oncology working group of SIAC.
Jose Alvarez-Cardona
Dr Jose Alvarez-Cardona is a Cardiologist and Assistant Professor at New York University School of Medicine, New York, US.
He received his medical degree from University of Puerto Rico School of Medicine. He specialises in cardiomyopathy and heart failure. His specialities include cardiac amyloidosis, cardiomyopathy and heart failure, congestive heart failure, heart transplant and left ventricular assist devices.
Dan Lenihan
Dr Dan Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Joe Carver
Dr Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, Philadelphia, US. He is the Chief of Staff at the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.